We're Here for You!
The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.
The IMF stands together with the Black community in calling for justice and racial equality. We believe unconditionally, that Black Lives Matter.
Watch the replay and learn more about current trends in myeloma treatment and research with this update from two major medical meetings held virtually in May and June 2020.
After a shutdown due to COVID-19, myeloma research continues with safety measures in place, says IMF Chairman Dr. Brian G.M. Durie. A new study shows the value of monitoring myeloma using blood testing, early good results are seen in the IMF-supported ASCENT trial, and details of a new scoring system used to diagnose high-risk smoldering myeloma have been submitted for publication.
Details about co-pay assistance programs for multiple myeloma patients.
With the growing concerns over the COVID-19 (coronavirus) outbreak, we want to ensure you have access to our resources. With a focus on the health and well-being of our staff, the IMF’s office will close on Friday, March 13, 2020. However, we are still here for you! Our entire staff will be working from home, and as always, we’re available.
Need to stay informed about the news that impacts myeloma patients, but don’t have time to read everything out there? Then be sure to follow Dr. Brian Durie’s Week in Review blog. The leading myeloma expert and IMF Chairman of the Board drills down on a wide range of topics – from the latest myeloma research results to the environmental issues that offer insight into prevention. He sifts through the data to deliver the bottom line.
The support of loved ones allows us to continue to fund efforts to search for a cure. Check out how Fundraisers are helping in the fight against myeloma.
